Tysabri (Natalizumab)

Tysabri is a monoclonal antibody prescription medication used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. Tysabri infusions for MS are aimed at slowing the progression of the disease; as such, they can be an effective part of an overall MS treatment plan.

Tysabri is also used to treat moderate to severe Chron’s disease.

https://www.tysabri.com

Indication:

  • Multiple Sclerosis

  • Chron’s Disease

A circular logo indicating a 1-hour process, with a blue arrow encircling the black number 1 and the word "HOUR" beneath, and a leaf symbol on the left side.

Infusion Duration:

1-hour (Additional observation period required upon initiation of therapy)

Frequency:

  • Every 4-6 weeks